Using biomarkers to solve challenges in drug development

Protein biomarkers provide a dynamic and powerful approach to identify and understand novel drug targets in early in drug development. The pharmaceutical industry utilizes biomarkers to help uncover disease progression markers, responder signatures, diagnostic biomarkers, and potential new indications.

In this virtual roundtable discussion the leading experts share their opinions on how biomarkers can help drive early clinical phase trials, discuss their work with biomarkers at present, explore the history of protein biomarkers within their organization, predict how the field will evolve to meet future challenges and advancements, panelists will also highlight potential challenges and issues that the pharmaceutical industry encounter during the use of protein markers in discovery and what needs to improve.

From this webinar, you will gain an understanding of the challenges and solutions behind the use of protein biomarkers in drug discovery, and appreciate the use of protein biomarker solutions for patient stratification by disease severity.

webinar November 23 2021

Olink Webinar library

Get access to this webinar, as well as the rest of our categorized library of more than 20 high-quality scientific webinars featuring presentations by leading researchers in their respective fields.

View webinar

Speakers

Dr. Jürgen Braunger of Boehringer Ingelheim Pharma

Dr. Timothy Radstake of AbbVie

Dr. Christopher D. Whelan of Biogen

2947

Biomarker assays

~881 million

Protein data points generated

907

Publications listed on website

Contact us!